Navigation Links
NeoTract Designates Dr. Ian M. Stormont as UroLift® Center of Excellence
Date:12/30/2019

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Dr. Ian M. Stormont MD, Grant Regional Health in Lancaster, WI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Stormont has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Ian M. Stormont has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #
For Teleflex Incorporated:
Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations

Media:
Nicole Osmer, 650.454.0504
nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Read the full story at https://www.prweb.com/releases/neotract_designates_dr_ian_m_stormont_as_urolift_center_of_excellence/prweb16805535.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. NeoTract Designates Dr. John Kefer as UroLift® Center of Excellence
2. NeoTract Designates Dr. Aaron Berger as UroLift® Center of Excellence
3. NeoTract Designates Dr. Garrett Matsunaga as UroLift® Center of Excellence
4. NeoTract Designates Dr. Bradley Wilson as UroLift® Center of Excellence
5. San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June
6. The White House Designates Mercy College a Bright Spot in Hispanic Education
7. United Benefit Advisors Designates Valued Pharmacy Services as Strategic Partner
8. Prevent Blindness Designates June as Cataract Awareness Month to Help Educate Public on Leading Cause of Vision Loss and Blindness
9. Urology of Virginia Announces Designation as UroLift® Center of Excellence
10. Chesapeake Urology Announces Dr. Sankar Kausik’s Designation as UroLift® Center of Excellence
11. Urologist Dr. Paul R. Kenworthy Designated a UroLift® Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2020)... ... 24, 2020 , ... At Allerio we have chosen to do things differently. ... We knew it had to be portable, it had to be reliable, it had ... work. , We are proud to announce that Allerio has passed all FCC and ...
(Date:6/24/2020)... ... 2020 , ... Skyroam , the developer of patented virtual SIM (vSIM) ... leading provider of enterprise software for testing laboratories, in which its Skyroam Solis Lite ... Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global ...
(Date:6/23/2020)... ... 2020 , ... Rritual , the premium brand in the emerging functional ... the President of North America’s leading mushroom adaptogens company. , Dr. Hart has ... his own family medicine clinic in London, Ontario, Canada where he regularly integrates plant-based ...
(Date:6/23/2020)... ... , ... A June 1 article on People reported on beauty ... opening back up while adjusting to new rules regarding public spaces, makeup experts expect ... covered such as eyelids, lashes, and brows. Beverly Hills Permanent Makeup agrees, saying now ...
(Date:6/23/2020)... ... June 22, 2020 , ... Advanced Kiosks , an ... line. Responding to an increased demand for improved building access control resulting from the ... NH based company is continuing to expand its products and services to meet the ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... , ... June 23, 2020 ... ... or the "Company"), a leading provider of center-based, Applied Behavioral Analysis ("ABA") ... rapidly-growing, center-based ABA provider in the greater-Indianapolis market. This acquisition will make ...
(Date:6/19/2020)... ... June 19, 2020 , ... The Covid-19 pandemic has had an ... a safe environment and compliant workforce is critical in the post-Covid world. , To ... popular SupplyBay vending machine below cost for a limited time only. , “We ...
(Date:6/19/2020)... ... June 19, 2020 , ... American ... Staffing Association (AHSA), a pioneer and leader in healthcare workforce solutions, will provide ... systems in the United States. AHTG and AHSA are part of the American ...
Breaking Medicine Technology: